MedTrace Logo

Pilot Study of Haloperidol to Treat Critical Illness Delirium

NCT00429676 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-11-14

No results posted yet for this study

Summary

The goal of this study is to determine whether haloperidol reduces the time on the breathing machine in critically ill patients with delirium.

Conditions

  • Delirium
  • Critical Illness

Interventions

DRUG

Haloperidol

Sponsors & Collaborators

  • Denver Health Medical Center

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Ivor S Douglas, MD · University of Colorado Department of Pulmonary and Critical Care Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00429676 on ClinicalTrials.gov